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Originating in the 1960s with the
landmark Framingham Heart Study,
a list of classical risk factors (hyper-
lipidemia, hypertension, smoking,
diabetes mellitus, physical inactivity,
obesity, endocrine dysfunction, and
abnormalities of hemostasis and
thrombosis) for atherosclerosis have
been identified (Table 1) (1–3). How-
ever, they were not sufficient to ac-
count for the etiology of this
multifactorial pathological process.
Therefore, several novel risk factors
have been identified, including micro-
bial pathogens, non-specific markers
for low-grade inflammation (4), fibrino-
gen, C-reactive protein (CRP), leuko-
cyte count and antibodies to
heat-shock proteins (5–14).
Possible focal origin for systemic
spread are the gastrointestinal system,
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Objectives: Links between periodontal diseases and systemic diseases have been
well documented by epidemiological studies. Recently, research has shifted to
elucidating the biologic mechanism for a causal relationship. One focus of interest
is atherosclerosis, the underlying event of cardiovascular diseases due to its serious
health impact. However, it is still not clear whether periodontopathic pathogens
are truly etiologic agents or ubiquitous bystanders. This article reviews the current
understanding about the molecular biological interactions between periodontal
disease and atherosclerosis and the biological plausibility of periodontitis as a
potential risk factor for cardiovascular disease.
Materials and methods: The current literature regarding periodontal diseases
and atherosclerosis and coronary vascular disease was searched using the Medline
and PubMed databases.
Results: In vitro experiments and animal models are appropriate tools to
investigate the biological interactions between periodontal disease and athero-
sclerosis at the cell molecular level. The concepts linking both pathologies refer to
inflammatory response, immune responses, and hemostasis. In particular,
Porphyromonas gingivalis appears to have unique, versatile pathogenic properties.
Whether or not these findings from isolated cells or animal models are applicable
in humans with genetic and environmental variations is yet to be determined.
Likewise, the benefit from periodontal therapy on the development of athero-
sclerosis is unclear. Approaches targeting inflammatory and immune responses of
periodontitis and atherosclerosis simultaneously are very intriguing.
Conclusion: An emerging concept suggests that a pathogenic burden from
different sources might overcome an individual threshold culminating in
clinical sequela. P. gingivalis contributes directly and indirectly to
atherosclerosis.
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bronchi, pharynx and periodontium
that harbor various putative etiologic
pathogens, namely Helicobacter spe-
cies, Chlamydia species, cytomegalo-
virus and Porphyromonas gingivalis
(15, 16). All putative pathogens for
atherosclerosis are associated with
chronic infections. Helicobacter pylori,
Chlamydia pneumoniae, cytomegalo-
virus, and P. gingivalis continually
sense and adapt to their environment
by expressing factors associated with
virulence (17). Although the contribu-
tion to atherogenesis of all putative
pathogens appears to be biologically
plausible, inconsistencies in statistical
association [e.g. H. pylori (18–21)],
detection in atheromatous plaques of
autopsy material [H. pylori (22), cyto-
megalovirus (23)] query the validity of
infection as a risk factor. The pene-
trance of 50% of the adults in the US
with atherosclerosis and seropositivity
for H. pylori, C. pneumoniae, and
cytomegalovirus might represent their
role as coincidental bystanders.
In this context, it is legitimate to
raise the question, whether and which
role P. gingivalis possibly could play.
Extensive epidemiological studies since
1989 have analyzed data related to a
statistical association of periodontal
disease (24). Variations in study
designs, sample number, end points for
cardiovascular disease and periodontal
disease, assessment of periodontium,
accumulation of systemic factors and
adjustment for confounding factors
might explain the conflicting range of
outcome. Even among prospective
cohort studies the degree of association
fluctuates from strong, e.g. odds ratio
2.68 (25) to negligible or no associ-
ation, e.g. hazard ratio 0.79 (26).
Gathering nine cohort studies in a
meta-analysis, the overall relative risk
settled at 1.19 (27). Interestingly, the
regression analysis uncovered an1 over-
estimation of 12.9% of the results
caused by residual confounding after
adjustment for risk factors. This illus-
trates the complexity of multifactorial
events.
Systemic effects of P. gingivalis
In order to consider periodontal dis-
ease as a risk factor for atherosclerosis,
the presence of pathogens associated
with periodontal disease should be
localized in serum or atheromatous
plaques. In addition, these pathogens
should induce the release of proin-
flammatory cytokines. Lastly, animal
models demonstrating atherosclerosis
induced by periodontal pathogen
should be available.
Among periodontal pathogens,
P. gingivalis has been recognized as a
key pathogen and risk factor for perio-
dontal disease (28–30). Its degree of
pathogenicity has been attributed to
various virulence factors. Most signifi-
cant is its ability to invade epithelial cells
(31, 32), connective tissue (33) and
endothelial cells (34). The invasion of
P. gingivalis is mediated through
up-regulation of adhesion molecules,
such as intercellular adhesion molecule
1 (ICAM-1), vascular cell adhe-
sion molecule 1 (VCAM-1), P- and
E-selectins, only in the presence of
fimbriae. The activation of adhesion
molecules is also required to bind leu-
kocytes to endothelium, which initiates
transmigration and atherogenesis (35)
(Fig. 1). A systemic host response is
elicited shown as elevated serum and
saliva antibody to P. gingivalis in




through cytokine production (tumor
necrosis factor, interleukin-1, prosta-
glandin E2). The concept of focus of
infection (38) and oral sepsis (39)
holds that transient bacteremias occur
from dental infection, surgical dental
procedures (40, 41), periodontal pro-
bing (42), and mastication (43).
Possible etiologic roles of periodon-
tal infections in atherogenesis include
bacteria and their byproducts dam-
aging the vessel wall and subsequent
metastatic infection. These events
indirectly promote atheroma forma-
tion through the inflammatory
response induced by periodontal or
metastatic infection (23).
Biopsy studies on carotid endarter-
ectomy specimens have demonstrated
the presence of periodontal pathogens
in atheromas (44). Forty-four per cent
of the atheromas were found to be
positive for at least one periodontal
pathogen. P. gingivalis was identified in
26% of the samples by polymerase
chain reaction.
Access of pathogens to systemic
circulation has been linked to
atherosclerosis and thrombus forma-
tion (45). Endothelial cell damage has
been shown to be promoted by the
ability of P. gingivalis to adhere,
invade, and proliferate in coronary
endothelial cells (34, 46, 47). This
phenomenon is believed to interfere
with the physiologic dilatory function
of the vessels through the pathogen’s
damage of the endothelial and
smooth muscle cells (48). When the
former in vitro findings were transla-
ted to a cohort study, this association
was further strengthened, as it was
found that periodontitis patients had
significantly compromised flow-medi-
ated dilation (49).
Similar evidence has been provided
in animal models, specifically the use
of apolipoprotein E-deficient mice
(apoE) (50). Although mice are in
general resistant to atherosclerosis,
inactivation of the apoE gene leads to
alterations in the lipid metabolism
(51). Therefore, apoE (–/–) mice are
known to develop atherosclerosis
spontaneously, whereas heterozygous
apoE (+/–) mice are more prone to
atherosclerosis compared to apoE
(+/+) mice (52, 53). In conjunction
with P. gingivalis, more pronounced
effects on alveolar bone loss, foam
Table 1. Risk factors implicated in athero-
genesis and periodontal disease
Not modifiable Modifiable













Bold type, mutual risk factor of athero-
sclerosis and periodontitis; regular type,
atherosclerosis risk factor.
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cell formation and atherosclerotic
lesions were consistently found in
inoculated apoE null mice. P. gingi-
valis was administrated by intraven-
ous injection (54) or by oral
inoculation (55). Several lines of evi-
dence confirm a role of P. gingivalis
on atherogenesis.
P. gingivalis' contribution to
initiating events of
atherosclerosis
Atherosclerosis is believed to be medi-
ated by inflammatory events (56).
Atheromas are a result of the progres-
sive accumulation of cholesterol and its
esters in macrophages of the intima,
termed foam cells (56–58). Cytokines
have been identified in the athero-
sclerotic plaque to regulate recruitment
of monocytes, endothelial adhesion
molecules, oxidized low-density lipo-
proteins (LDL) uptake, smooth muscle
cell proliferation, and hemostatic fac-
tors (45, 59, 60). The release of cyto-
kine from macrophages and other cells
is thought to be triggered by bacterial
components leading to systemic acti-
vation of phagocytic cells, a mechan-
ism well know to be associated
with P. gingivalis lipopolysaccharide
(57, 61). Prostaglandin E2, interleukin-
1b, and tumor necrosis factor-a
derived from periodontitis reach high
and potent systemic levels (62). This
increased release of proinflammatory
cytokines actively recruits more
inflammatory cells, which furthermore
may result in higher counts of foam
cells.2 For example, endothelial cells
stimulated by bacterial products re-
lease monocyte attractant protein-1
(MCP-1). MCP-1 mediates transen-
dothelial migration of monocytes via
chemotaxis. Mice with deficient levels
of MCP-1 have been shown to have
less atherosclerotic plaque develop-
ment (63). However, it has been shown
that P. gingivalis induces MCP-1 in
endothelial cells in vitro (64). This im-
plies that P. gingivalis may contribute
to the development of atherosclerosis.
However, the molecular mechanism of
this finding requires in depth elucida-
tion.
Development of atherosclerotic
lesion requires foam cell
formation
Cholesterol-laden macrophages, or as
foam cells, are indispensable in the
progression of atherogenesis and pla-
que instability. Components of P. gin-
givalis increase the uptake of LDL in
murine macrophages (65). This has
also been shown to induce foam cell
formation in human umbilical vein
endothelial cells (66). Cholesterol
accumulations in macrophages are the
hallmark of atherosclerotic lesions
(Fig. 1). The uptake of LDL by macro-
phages requires oxidation to oxLDL.
The oxidation is driven by the genera-
tion of reactive oxygen intermediates
in macrophages in the vessel wall in
response to bacteria. Macrophages
transform to foam cells and stimulate
the production of proinflammatory
cytokines, leading to endothelial dys-
function.
Periodontitis is known as a potent
source for reactive oxygen intermedi-



































Fig. 1. Process of atherogenesis and role of direct and indirect periodontal factors. Periodontal pathogens may directly and indirectly affect
blood cells and blood vessels resulting in foam cell formation, the hallmark of atherosclerosis. CRP, C-reactive protein; Hsp, heat shock
protein; IL-1b, interleukin-1b; MCP-1, monocyte attractant protein-1; M-CSF, macrophage colony-stimulating factor; oxLDL, oxidized low-
density lipoprotein; PGE2, prostaglandin E2; ROI, rate of infection; TNF-a, tumor necrosis factor-a; VCAM, vascular cell adhesion molecule.8
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periodontitis and lipid deposition in
the aorta was shown in a rabbit model
(68). Periodontitis was induced by
topical application of P. gingivalis
and the correlation remained strong,
although two out of five rabbits of the
P. gingivalis-treated group failed to
develop periodontitis and lipid depo-
sitions. Future studies are needed to
confirm this interesting finding.
Immunologic response and lesion
progression
Smooth muscle cells proliferate during
progression to a fibrous cap into the
subendothelial space where they take
up oxLDL and form extracellular
matrix (58). The T-cell response further
contributes to foam cell formation
and smooth muscle formation through
cytokine production.
Another immunologic-related mech-
anism involves the homology of bac-
terial heat shock proteins (Hsp) with
host proteins, which may lead to cross-
reactivity. T-cells and antibodies may
recognize epitopes shared by both host
and infectious organism Hsps, thereby
initiating and/or perpetuating athero-
sclerotic plaque formation (13, 14).
Among several other human tissues,
Hsp is produced in the endothelium
lining the vessel wall. It responds to
certain stressors, such as high blood
pressure and exposure to lipopolysac-
charide, by producing Hsp60 (69),
antibodies and facilitating cross-reac-
tions. This immunological cross-reac-
tion might result in cell damage and
proliferation of smooth muscle cells
(70). P. gingivalis has an Hsp60 (71)
and an Hsp90 homologue (5), which
were found to cross-react with the
corresponding human Hsp. It has been
illustrated that patients with higher
levels of anti-Hsp antibodies had less
destruction of periodontal tissues (72).
Conversely, the inability to produce
anti-Hsp antibodies might contribute
to tissue destruction induced by
pathogens.
Recent animal models using
immunization with human Hsp60 have
confirmed the role of Hsps for athero-
genesis (73, 74). Besides the significant
development of fatty streaks, perio-
dontal inflammation was present in the
test group (74). A T-cell response spe-
cific to Hsp60 of P. gingivalis was
found in the serum and atheromas of
patients with periodontal disease and
atherosclerosis (75–77). Interestingly,
this T-cell response appears to be
characteristic for P. gingivalis; it failed
to demonstrate association with other
periodontal pathogens, e.g. Actinoba-
cillus actinomycetemcomitans, Capno-
cytophaga sputigena, and Eikenella
corrodens (76). Evidence suggests that
P. gingivalis Hsps circulate in the
blood and eventually cross-react with
endothelium and atheroma. Immune-
based therapy might be a promising
approach for atherosclerosis and
periodontal diseases, in particular
refractory cases. Nevertheless, the
molecular interactions need to be fur-
ther elucidated first.
Elevated serum levels of CRP, an
acute-phase reactant to inflammation,
is induced by non-specific, local and
systemic tissue damage, infection and
inflammation. Evidence from well-
conducted prospective studies identi-
fied CRP as a strong marker of future
vascular events (78–81). Only high-
sensitivity CRP assays are valid to
predict future cardiovascular events,
with a serum concentration of <1, 1–3
and >3 lg/ml considered as low, in-
termediate and high risk, respectively,
for a cardiovascular event. CRP is
linked to atherogenesis through pro-
duction of cytokines such as inter-
leukin-1, interleukin-6, tumor necrosis
factor-a, and interferon-c. Binding of
LDL and formation of foam cells is
mediated by CRP (82–85). The ter-
minal complement complex (C5b-9) is
activated (86–88). In addition to sys-
temic effects, CRP might be amplified
by local CRP accumulation in athero-
mas (89). Cross-sectional data revealed
a positive correlation of CRP levels
and markers3 of endothelial dysfunction
(90, 91). However, the carotid intimal
medial thickness detected by ultra-
sound failed to demonstrate a direct
effect (84, 92). In contrast to studies
before 2000, evidence from a large
scale meta-analysis including 22 pros-
pective studies showed a decrease in
odds ratio of CRP as a marker for
coronary heart disease and resulted in
an overall odds ratio of 1.58 (93).
As periodontitis has a high incidence
in an adult population and because of
the chronic nature of the disease, it
seems likely that it also affects the body
systemically. The systemic effect of
periodontitis has been shown in a
positive association between increased
CRP levels and periodontitis by several
groups in cross-sectional and pros-
pective studies (94–102). CRP appears
to be consistently elevated in a dose–
response fashion to the pathogenic
burden of periodontal bacteria (96, 98,
103, 104). As part of the Erie County
study (28), serum samples and carotid
endarterectomy samples were taken
from 16 subjects. These subjects had
periodontal disease, defined as a mean
attachment loss of ‡ 4 mm, and a
positive history of cardiovascular dis-
ease. In a follow-up study, the serum
was analyzed for CRP by enzyme-
linked immunosorbent assay and
immunohistochemistry (100). In the
presence of both diseases, CRP was
significantly elevated in 75% of the
subjects, with a mean CRP level of
8.58 lg/ml, compared to 39% in the
absence of both diseases and a
CRP level of 1.68 lg/ml. Non-surgical
intervention consisting of scaling and
root planing and antibiotics resulted in
reduced CRP levels (105). Interest-
ingly, baseline CRP was elevated only
in a fraction of the patients who pre-
ferentially demonstrated the decrease
of CRP. This suggests that the associ-
ation of CRP and periodontal disease
is more dimensional. In addition, the
sensitivity of the CRP testing method
and its specificity for periodontitis vs.




During the progression of a fibrous
plaque, atheroma cells4 may undergo
apoptosis, necrosis, and mineralization
culminating in release of lipids and
further narrowing of the vessel lumen.
Plaque rupture subsequently leads to
thrombosis of the vessel, the underly-
ing biological event of ischemia and
myocardial infarction (56, 106, 107).
The coagulation cascade is simulta-
neously initiated.
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Destabilization of pre-existing athe-
rosclerotic plaques occurs in the pres-
ence of vascular stenosis. Oral bacteria
stimulate platelet aggregation and
thrombus-like formation in vitro (108).
When Streptococcus sanguis was in-
fused in rabbits, it was shown that
myocardial, infarction-like symptoms
were developed in a dose-dependent
manner (109). Among several perio-
dontal pathogens, P. gingivalis was the
only one to trigger platelet aggregation
(110). It was demonstrated that
P. gingivalis vesicles and fimbriae are
critical for aggregation and adherence,
respectively. Furthermore, P. gingiva-
lis-induced platelet aggregation might
precede thromboembolic events.
Matrix metalloproteinases derived
from macrophages are thought to
weaken the fibrous cap of the athe-
roma, thus promoting plaque rupture.
Periodontal pathogens are known to
induce matrix metalloproteinases and
might contribute to plaque rupture
(111). In vitro, P. gingivalis has dem-
onstrated the ability to degrade human
atheroma samples.5
Clinical signs of atherosclerosis
in the presence of periodontal
disease
Imaging and laboratory diagnostics
are suitable tools to detect subclinical
evidence for atheromatous plaques
and occurrence/progression. The state-
of-the-art imaging diagnostics of new
atheromatous plaques and occurrence/
progression of vessel stenosis include
high-resolution duplex scanning
(ultrasound) with a 10-MHz imaging
probe and 5-MHz Doppler probe. The
high resolution allows valid evaluation
of the intima-media thickness and
changes of the carotid vessel wall over
time (112, 113).
In accordance with chronic, sys-
temic infections, a dose-dependent
effect was found in severe periodontal
disease related to the intima-media
wall thickness of the carotid artery
(114). This large-scale cross-sectional
study was part of the Atherosclerosis
Risk in Communities (ARIC) study.
The disease definitions included an
increase in vessel wall thickness by
ultrasound of ‡ 1 mm, and attachment
loss ‡ 3 mm in ‡ 30% of sites was
considered severe periodontal disease.
The adjusted odds ratio was 1.3. The
odds ratio was 1.6 for positive B-mode
ultrasound findings of carotid artery
plaque, using tooth loss as an indicator
of past periodontal disease6 (115). The
results offered first evidence for a
contribution of periodontal pathogens
during early atherogenesis, which
strengthens the connection between
periodontitis and vascular events
towards a causal one.
Discussion
The focus of the relationship between
cardiovascular disease and periodontal
disease is shifting from a purely epi-
demiological association towards bio-
logic understanding of the underlying
mechanism. Current evidence provided
by cross-sectional and longitudinal
studies has been inconclusive. Con-
spicuously, several important risk
factors are known to contribute to
both conditions mutually (Table 1).
Although adjustment for known risk
factors is routinely considered in
epidemiological studies, residual con-
founding might has to be anticipated
(27).
To address the issue of causality,
studies based upon plausible biologic
concepts between atherogenesis and
periodontal diseases are needed, using
in vitro cell cultures, animal models,
and controlled intervention studies
based on molecular markers. Within
the limitations of in vitro study models
in the basic sciences, the biologic
plausibility for a causal relationship
seems to be coherent. Direct and indi-
rect biologic connections between per-
iodontitis and atherosclerosis have
been demonstrated at different stages
of atherogenesis (Table 2). Positive
findings of periodontal pathogens in
circulation and cardiovascular athero-
mas are a necessary requirement for
local invasion of endothelial cells and
for inoculation of pre-existing athero-
sclerotic plaques. It is possible that
P. gingivalis affects the vessel wall
directly and/or indirectly via inflam-
matory response, immune responses,
and hemostasis. The inflammatory
host response does not have to be
exclusively triggered by P. gingivalis. A
current hypothesis suggests an additive
or synergistic effect resulting from
coincidental bystanders of different
origins. Together as total pathogenic
burden they might overcome a certain
threshold resulting in unequivocal
clinical significance.
The connection between various
chronic infection and markers of early
atherogenesis was prospectively inves-
tigated over 5 years in a large popula-
tion (116). The adjusted odds ratio of
2.78 expressed the chances for partici-
pants with a chronic infection to
develop atherosclerosis. A total of
36.8% of individuals suffered from
chronic infections, and periodontitis
was present in 2.3% of patients. It was
concluded that approximately 40% of
the newly developed atheromas were
attributable to chronic infection.
Further, bacterial endotoxins and the
autoantibody Hsp60 were elevated.
Bacterial load was found to correlate
with the extent of atherosclerosis and
even cardiovascular death, which was
even stronger in patients with a high
CRP level, possibly representing more
inflammation (117–119). The lack of
association between endodontically
treated teeth and periapical pathology,
generally involving only a few teeth,
and cardiovascular disease cross-sec-
tional study might support this concept
(120).
Infections may potentiate the action
of traditional risk factors. Neverthe-
less, there is no direct evidence that
these organisms cause atherosclerotic
lesions according to Koch’s postulates.
Animal models have been used to
study the pathogenesis of multifacto-
rial diseases in an attempt to exclude
potentially confounding risk factors
except the one of interest. Related to
P. gingivalis the accumulation of risk
factors, such as genetic predisposition,
diet and infection, appeared to have an
additive effect on the lesions (54).
Assuming a true causal link between
atherosclerosis and periodontal dis-
ease, periodontal treatment is to be
expected to reduce the risk of athero-
sclerosis and cardiovascular disease.
All other results have to be interpreted
as biases attributed to confounding
(121). Intervention approaches aiming
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at the elimination of periodontal
pathogens using conventional perio-
dontal therapy include antibiotics or
extraction.7 However, intervention
studies on the establishment of a
decreased risk in atherosclerosis as a
result of periodontal treatment have
yet to be published. So far, on an
epidemiological basis, edentulous
patients have not been shown to have a
lower risk for coronary heart disease
(122). Whether or not these effects on
isolated cells or in animal models are
applicable in human subjects with
genetic and environmental variations
is yet to be determined. Compared
to other infectious diseases, the treat-
ment of chronic periodontitis on a
long-term basis may prove to be more
demanding due to its multifactorial
etiology.
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